Artwork

Innhold levert av The Appetite and Opal: Food+Body Wisdom. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Appetite and Opal: Food+Body Wisdom eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

#132: Weight Loss Medications: Are GLP-1 Agonists a Game Changer ?

34:12
 
Del
 

Manage episode 430398741 series 2459290
Innhold levert av The Appetite and Opal: Food+Body Wisdom. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Appetite and Opal: Food+Body Wisdom eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Dr. Lisa Erlanger returns to the podcast for a conversation with Julie Church, RDN, CD on GLP-1 agonists, medications widely prescribed for weight loss. Through a weight-inclusive lens, Lisa explains GLP-1 agonists history, current use, and side effects with a special attention given to the unique considerations for individuals with current or past eating disorders. Spoiler alert--- these medications are not game changers, bodies still need food and nourishment to thrive! Despite what the shiny marketing says about these being "miracle drugs", safe and long-term weight suppression is not possible.

To find Lisa: Dr. Lisa Erlanger's website

As mentioned on show: GLP-1 Agonist Medications: Informed Consent Resource

Medical Students for Size Inclusive Medicine

Dr. Lisa Erlanger's Appetite Podcast interview, A Physicians Journey to Weight Inclusive Medicine

Connect with Opal:

www.opalfoodandbody.com

@opalfoodandbody

@Opal.Movement

Thank you to our team...

Editing by David Bazzi

Music by Aaron Davidson: https://soundcloud.com/diet75/

Sound engineering by Ayesha Ubayatilaka at Jack Straw Studios

  continue reading

131 episoder

Artwork
iconDel
 
Manage episode 430398741 series 2459290
Innhold levert av The Appetite and Opal: Food+Body Wisdom. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Appetite and Opal: Food+Body Wisdom eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Dr. Lisa Erlanger returns to the podcast for a conversation with Julie Church, RDN, CD on GLP-1 agonists, medications widely prescribed for weight loss. Through a weight-inclusive lens, Lisa explains GLP-1 agonists history, current use, and side effects with a special attention given to the unique considerations for individuals with current or past eating disorders. Spoiler alert--- these medications are not game changers, bodies still need food and nourishment to thrive! Despite what the shiny marketing says about these being "miracle drugs", safe and long-term weight suppression is not possible.

To find Lisa: Dr. Lisa Erlanger's website

As mentioned on show: GLP-1 Agonist Medications: Informed Consent Resource

Medical Students for Size Inclusive Medicine

Dr. Lisa Erlanger's Appetite Podcast interview, A Physicians Journey to Weight Inclusive Medicine

Connect with Opal:

www.opalfoodandbody.com

@opalfoodandbody

@Opal.Movement

Thank you to our team...

Editing by David Bazzi

Music by Aaron Davidson: https://soundcloud.com/diet75/

Sound engineering by Ayesha Ubayatilaka at Jack Straw Studios

  continue reading

131 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett